[1] 冯梦林,卫心怡,王楠娅,等. 过表达IncRNA AC079466.1通过内质网应激信号通路对非小细胞肺癌细胞凋亡的影响[J]. 中国药理学通报,2023,39(9):1689-1695. DOI:10.12360/CPB202304039.
[2] Kang DY, Sp N, Lee JM, et al. Antitumor effects of ursolic acid through mediating the inhibition of STAT3/PD-L1 signaling in non-small cell lung cancer cells[J]. Biomedicines, 2021, 9(3):297. DOI: 10.3390/biomedicines9030297.
[3] 常春禹. 非小细胞肺癌放疗致放射性心脏损伤的研究进展[J]. 检验医学与临床,2023,20(5):712-716. DOI:10.3969/j.issn.1672-9455.2023.05.034.
[4] Wang B, Wang X, Tseng Y, et al. Distinguishing colorectal adenoma from hyperplastic polyp by WNT2 expression[J]. J Clin Lab Anal, 2021, 35(10): e23961. DOI: 10.1002/jcla.23961.
[5] Chen X, Liu Y, Zhang Q, et al. Exosomal miR-590-3p derived from cancer-associated fibroblasts confers radioresistance in colorectal cancer[J]. Mol Ther Nucleic Acids, 2020, 24: 113-126. DOI: 10.1016/j.omtn.2020. 11.003.
[6] Li H, Huang B. miR-19a targeting CLCA4 to regulate the proliferation, migration, and invasion of colorectal cancer cells[J]. Eur J Histochem, 2022, 66(1):3381. DOI: 10.4081/ejh.2022.3381.
[7] 中华医学会,中华医学会肿瘤学分会,中华医学会杂志社. 中华医学会肺癌临床诊疗指南(2019版)[J]. 中华肿瘤杂志,2020,42(4):257-287. DOI: 10.3760/cma.j.cn112152- 20200120-00049.
[8] Gomez-Larrauri A, Gangoiti P, Camacho L, et al. Phosphatidic acid stimulates lung cancer cell migration through interaction with the LPA1 receptor and subsequent activation of MAP kinases and STAT3[J]. Biomedicines, 2023, 11(7):1804. DOI: 10.3390/biomedicines11071804.
[9] Tantawy MA, Shaheen S, Kattan SW, et al. Cytotoxicity, in silico predictions and molecular studies for androstane heterocycle compounds revealed potential antitumor agent against lung cancer cells[J]. J Biomol Struct Dyn, 2022, 40(10):4352-4365. DOI: 10.1080/07391102.2020. 1856188.
[10] 侯聪霞,孙芳,梁亚林,等. 特瑞普利单抗联合含铂双药化疗治疗TP53基因突变非小细胞肺癌的疗效[J]. 实用癌症杂志,2023,38(4):585-588. DOI: 10.3969/j.issn.1001-5930. 2023.04.016.
[11] 齐泽铖,李旭,郭英伟,等.TAK1与TCF-4在非小细胞肺癌中表达及其相关性的初步研究[J].广州医药,2023,54(6):17-22.DOI:10.3969/j.issn.1000-8535.2023. 06.003.
[12] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
[13] Sun R, Hou Z, Zhang Y, et al. Drug resistance mechanisms and progress in the treatment of EGFR-mutated lung adenocarcinoma[J]. Oncol Lett, 2022, 24(5):408. DOI: 10.3892/ol.2022.13528.
[14] Danni X, Jiangzheng Z, Huamao S, et al. Chaperonin containing TCP1 subunit 3 (CCT3) promotes cisplatin resistance of lung adenocarcinoma cells through targeting the Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) pathway[J]. Bioengineered, 2021, 12(1): 7335-7347. DOI: 10.1080/21655979.2021.1971030.
[15] 宋娜莎. PD-1/PD-L1通路相关精准靶向治疗对肺癌患者预后及NSE、CYFRA21-1和CA19-9水平的影响分析[J]. 实用癌症杂志,2022,37(8):1309-1311,1319. DOI:10.3969/j.issn.1001-5930.2022.08.024.
[16] 陈慧莉,李立,朱美娜.乳腺癌患者血浆中miR-501-5p、CLCA4 mRNA的表达及其诊断价值[J].中国医师杂志,2022,24(6):947-950.DOI:10.3760/cma.j.cn431274- 20210716-00764.
[17] Horaira MA, Islam MA, Kibria MK, et al. Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents[J]. BMC Med Genomics, 2023, 16(1): 64. DOI: 10.1186/s12920-023- 01488-w.
[18] Jin Y, Kang Y, Wang M, et al. Targeting polarized phenotype of microglia via IL6/JAK2/STAT3 signaling to reduce NSCLC brain metastasis[J]. Signal Transduct Target Ther, 2022, 7(1):52. DOI: 10.1038/s41392-022- 00872-9.
[19] Chou JC, Lieu FK, Ho DM, et al. Regulation of extracellular and intracellular prolactin on cell proliferation and survival rate through GHR/JAK2/STAT3 pathway in NSCLC[J]. Chemosphere, 2021, 264(Pt 1): 128604. DOI: 10.1016/j.chemosphere.2020.128604.
[20] Sun Y, Gao Y, Dong M, et al. Kremen2 drives the progression of non-small cell lung cancer by preventing SOCS3-mediated degradation of EGFR[J]. J Exp Clin Cancer Res, 2023, 42(1):140. DOI: 10.1186/s13046-023- 02692-3.
[21] Zhuang Y, Ma Y, Yan S, et al. Cyy260, a novel small molecule inhibitor, suppresses non-small cell lung cancer cell growth via JAK2/STAT3 pathway[J]. Am J Cancer Res, 2021, 11(9):4241-4258.
[22] 张雅丽,周芬. miR-373调控JAK3/STAT6信号通路抑制肿瘤相关巨噬细胞M2极化对肺癌细胞的影响[J]. 中国免疫学杂志,2023,39(10):2055-2061. DOI:10.3969/j.issn. 1000-484X.2023.10.007.
[23] Sp N, Kang DY, Lee JM, et al. Mechanistic insights of anti-immune evasion by nobiletin through regulating miR-197/STAT3/PD-L1 Signaling in Non-Small Cell Lung Cancer (NSCLC) Cells[J]. Int J Mol Sci, 2021, 22(18): 9843. DOI: 10.3390/ijms22189843.
[24] Wang B, Li J, Li Y, et al. MiR-630 suppresses non-small cell lung cancer by targeting vimentin[J]. J Clin Lab Anal, 2022, 36(9): e24536. DOI: 10.1002/jcla.24536.
[25] Ma J, Chen S, Liu Y, et al. The role of exosomal miR-181b in the crosstalk between NSCLC cells and tumor-associated macrophages[J]. Genes Genomics, 2022, 44(10):1243-1258. DOI: 10.1007/s13258-022-01227-y.
[26] Xie Y, Zheng ZW, He HT, et al. LncRNA NEAT1 induces autophagy through the miR-128-3p/ADAM28 axis to suppress apoptosis of nonsmall-cell lung cancer[J]. Kaohsiung J Med Sci, 2022, 38(10): 933-949. DOI: 10.1002/kjm2.12582.
[27] Wu Y, Liu C, Niu Y, et al. Procyanidins mediates antineoplastic effects against non-small cell lung cancer via the JAK2/STAT3 pathway[J]. Transl Cancer Res, 2021, 10(5): 2023-2035. DOI: 10.21037/tcr-20-3018.
[28] 祖翡翠,魏海霞,韩春兰,等. JAK2/STAT3信号通路在柴胡皂苷D调控非小细胞肺癌H460细胞增殖、凋亡过程中的作用研究[J]. 临床肺科杂志,2023,28(5):718-724. DOI:10.3969/j.issn.1009-6663.2023.05.015.
[29] Xiong JW, Song SB, Xiong LM, et al. CircRPPH1 promotes cell proliferation, migration and invasion of non-small cell lung cancer via the PI3K/AKT and JAK2/STAT3 signalling axes[J]. J Biochem, 2022, 171(2): 245-252. DOI: 10.1093/jb/mvab129.
[30] Luo DD, Zhao F. KLF4 suppresses the proliferation and metastasis of NSCLC cells via inhibition of MSI2 and regulation of the JAK/STAT3 signaling pathway[J]. Transl Oncol, 2022, 22:101396. DOI: 10.1016/j.tranon.2022. 101396.
[31] 蒋可心,李宁,张旭. 钙激活的氯离子通道A4通过抑制JAK激酶2/信号转导及转录激活蛋白3信号通路对食管癌细胞增殖、迁移及侵袭的影响[J]. 安徽医药,2021,25(3):474-478. DOI:10.3969/j.issn.1009-6469.2021.03.010.
|